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Interferons initiate the host antiviral response
by inducing a number of genes, most with no
defined antiviral function. Here we show that
the interferon-induced protein viperin inhibits
influenza A virus release from the plasma mem-
brane of infected cells. Viperin expression al-
tered plasma membrane fluidity by affecting
the formation of lipid rafts, which are deter-
gent-resistantmembranemicrodomains known
to be the sites of influenza virus budding. Intra-
cellular interaction of viperin with farnesyl di-
phosphate synthase (FPPS), an enzyme es-
sential for isoprenoid biosynthesis, decreased
the activity of the enzyme. Overexpression of
FPPS reversed viperin-mediated inhibition of
virus production and restored normal mem-
brane fluidity, and reduction of FPPS levels by
siRNA inhibited virus release and replication, in-
dicating that the FPPS interaction underlies vi-
perin’s effects. These findings suggest that tar-
geting the release stage of the life cycle may
affect the replication of many enveloped vi-
ruses. Furthermore, FPPS may be an attractive
target for antiviral therapy.
INTRODUCTION
Interferons (IFNs) represent the first line of defense against
viral infection. Hundreds of genes are regulated by IFN
(Samuel, 2001), and their products are the mediators of
the host antiviral response. Many steps in the viral replica-
tion cycle are potential targets of IFN-inducible proteins.
PKR, which binds double-stranded (ds) RNA, phosphory-
lates eIF2a and blocks de novo protein synthesis (Clem-
ens and Elia, 1997). 20-50 oligoadenylate synthase (OAS),
another dsRNA-binding protein, catalyzes the synthesis
of 20-50 oligoadenylates (Kerr and Brown, 1978) and acti-
vates the latent endoribonuclease RNaseL, which then
degrades single-stranded RNAs and halts viral replication
(Player and Torrence, 1998). The Mx GTPase disrupts the
nuclear replication phase of RNA viruses (Kochs and96 Cell Host & Microbe 2, 96–105, August 2007 ª2007 ElsevierHaller, 1999a, 1999b). ISG15 blocks ubiquitination of
Gag and Tsg101 and subsequently inhibits the release of
HIV (Okumura et al., 2006). However, the mechanisms
of action of the vast majority of IFN-inducible proteins
remain unexplored.
Viperin is an evolutionarily conserved protein that is
highly inducible by both type I and type II IFNs (Chin and
Cresswell, 2001). It has been identified in organisms as di-
verse as fish (Boudinot et al., 2000; Sun and Nie, 2004), ro-
dents (Grewal et al., 2000), and primates (Chin and Cress-
well, 2001; Zhu et al., 1997). Infection by many viruses
strongly induces viperin expression (Boudinot et al.,
2000; Chin and Cresswell, 2001; Helbig et al., 2005; Khai-
boullina et al., 2005; Zhu et al., 1997), suggesting a role in
the host antiviral response. Moreover, we previously
showed that pre-expression of viperin in human fibro-
blasts significantly inhibits the replication of human cyto-
megalovirus (hCMV) (Chin and Cresswell, 2001). Recently,
viperin has also been shown to be important for the host
anti-HIV responses (Rivieccio et al., 2006).
In this study, we demonstrate that expression of viperin
inhibits influenza virus replication by perturbing its release
from the plasma membrane. Influenza virus buds from
lipid rafts, and we find that viperin expression disrupts
the plasmamembrane by perturbing lipid rafts in amanner
dependent on the ability of viperin to bind and inhibit
FPPS, an enzyme involved in the synthesis of multiple iso-
prenoid-derived lipids. Strikingly, viperin does not affect
the replication of vesicular stomatitis virus (VSV), which
also buds from the plasma membrane but does not
require lipid rafts to do so.
RESULTS
Establishing a Viperin-Inducible Cell System
Pathogens such as viruses, and virus-derived pathogen-
associated molecular patterns such as dsRNA, are potent
IFN inducers. After secretion, IFN binds to its receptor and
activates the JAK-STAT pathway, which induces the ex-
pressionof responsive genes, including viperin (Figure 1A).
To facilitate the analysis of the antiviral mechanism of
viperin, we generated a stable HeLa Tet-on-derived cell
line in which mouse viperin can be specifically induced
by doxycycline and the level of expression regulated by
varying the doxycycline concentration (Figure 1B andInc.
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cline at 2 mg/ml because the level of expression at this
concentration is comparable to the endogenous viperin
level induced by IFN-b treatment of bone marrow-derived
macrophages (BMMph) (Figure 1C). Doxycycline-induced
viperin colocalized with the endoplasmic reticulum (ER)
Figure 1. Establishment of HeLa Tet-on Viperin-Inducible
Cells
(A) Expression of viperin in mousemacrophages. Primary mouse mac-
rophages were treated with 200 U/ml IFNb, 200 U/ml IFNg, or 40 mg/ml
dsRNA or infected with influenza A/WSN virus at an moi of 3.
(B) Expression of mouse viperin in HeLa Tet-on viperin-inducible cells.
HeLa Tet-on vector-alone cells or HeLa Tet-on viperin-inducible cells
were untreated () or treated (+) with 2 mg/ml doxycycline for 16 hr.
(C) Levels of viperin expression in HeLa Tet-on viperin-inducible cells
and bone marrow-derived macrophages (BMMph). HeLa Tet-on vi-
perin cells were either untreated or treated with 0.2 mg/ml or 2 mg/ml
doxycycline for 24 hr. BMMph were either untreated or treated with
500 U/ml IFNb for 6 hr or 24 hr. Twenty micrograms of total cell lysates
were loaded.
(D) HeLa Tet-on cells do not express endogenous human viperin.
HeLa Tet-on viperin-inducible cells were treated with 500 U/ml IFNb,
500 U/ml IFNg, 2 mg/ml doxycycline, 1 mg/ml LPS, or 50 mg/ml dsRNA,
or mock infected or infected with influenza A/WSN or A/PR8 at an moi
of 3. Cell lysates from (A)–(D) were subjected to SDS-PAGE and west-
ern blot analysis using an antiserum recognizing both human and
mouse viperin. GAPDH was used as a loading control.
(E) Viperin localizes to the ER in viperin-inducible cells. The cells were
treated with doxycycline for 24 hr and stained with a mouse monoclo-
nal anti-viperin antibody and a rabbit antiserum to calnexin, followed
by Alexa 488-conjugated goat anti-mouse Ig and Alexa 546-conjuated
goat anti-rabbit Ig secondary antisera. Images were acquired using
a Leica TCS SP2 confocal microscope.Cell Hmarker calnexin (Figure 1E), which is consistent with the
normal intracellular distribution of human viperin (Chin
and Cresswell, 2001). Endogenous human viperin was
not detectable in this cell line after treatment with IFN,
LPS, dsRNA, or influenza A virus infection (Figure 1D).
This is consistent with earlier observations for HeLa cells
(Chin and Cresswell, 2001), and it avoids potential exper-
imental complications caused by endogenous viperin
expression.
Viperin Expression Inhibits Influenza Virus
Replication by Blocking Viral Release
from the Plasma Membrane
We previously showed that expression of viperin affected
the replication of hCMV. The complexity of the hCMV
replication cycle, however, has hindered analysis of the
mechanism. We therefore elected to use influenza A,
a negative-stranded RNA virus, as a model virus. Viperin
was strongly induced in primary mouse macrophages by
influenza A/WSN virus infection (Figure 1A), and a similar
response was observed upon infection of mouse embry-
onic fibroblasts (data not shown), suggesting that viperin
may play a role in the host anti-influenza response.
To determine whether viperin expression could inhibit
influenza A/WSN virus replication, viperin-inducible cells
or vector control cells were overnight pretreated with
doxycycline or left untreated, and then infected with
A/WSN virus at a multiplicity of infection (moi) of 0.02.
Virus replication was substantially inhibited by the expres-
sion of viperin. At 48 hr postinfection, approximately 107
plaque-forming units (PFU)/ml were obtained from control
cells, whether or not they were treated with doxycycline,
or from untreated viperin-inducible cells (Figure 2A). In
contrast, only 104 PFU/ml were obtained from doxycy-
cline-treated viperin-inducible cells (Figure 2A). Influenza
A/WSN replication was consistently inhibited upon doxy-
cycline treatment of multiple viperin-inducible clones
(data not shown).
To investigate the antiviral mechanism, we first wished
to determine the step of the viral replication cycle targeted
by viperin. A productive infection by influenza A virus be-
gins when it binds to its cell surface receptor, sialic acid.
The bound virus is subsequently internalized by endocyto-
sis, and the acidic endosomal pH triggers membrane fu-
sion, releasing the viral genome into the cytosol and ulti-
mately the nucleus, where viral mRNA synthesis and
genome replication occur. Viral mRNAs enter the cytosol
and initiate viral protein synthesis. The viral transmem-
brane glycoproteins, hemagglutinin (HA) and neuramini-
dase (NA), traffic to lipid rafts in the plasma membrane
where viral budding takes place (Leser and Lamb, 2005;
Scheiffele et al., 1999). The matrix protein (M1), nuclear
export protein (NEP), and the nucleoprotein (NP) move
to the nucleuswhere, with assistance from cellular factors,
they form the nucleocapsid. The nucleocapsid translo-
cates the viral genome to the cytosol and finally to the
plasma membrane. Here the viral replication cycle culmi-
nates in the assembly and release of progeny virions
(Lamb and Krug, 2001). No significant effects of viperinost & Microbe 2, 96–105, August 2007 ª2007 Elsevier Inc. 97
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tion, including receptor binding (Figure S1A in the Supple-
mental Data available with this article online), viral genome
replication (data not shown), protein synthesis, protein
stability (Figure S1B), and protein localization (Figure S1C).
However, viral release was severely inhibited by viperin
expression. Doxycycline treatment of the inducible cells
led to an 80% reduction in released virus compared to
Figure 2. Viperin Expression Inhibits Influenza A Virus Repli-
cation and Release
(A) Expression of viperin inhibits influenza A/WSN virus replication.
Control cells or viperin-inducible cells were untreated or treated with
doxycycline for 16 hr and infected with influenza A/WSN virus at an
moi of 0.02. Viral titers were determined at 24, 48, and 72 hr postinfec-
tion by plaque assay.
(B) Expression of viperin inhibits influenza A/WSN virus release. Vi-
perin-inducible cells were untreated () or pretreated (+) with doxycy-
cline for 24 hr and infected with influenza A/WSN virus at an moi of 3.
After 16 hr, cells were labeled with 35S-methionine and cysteine for
20 min and chased for 2, 4, and 6 hr. Viral proteins released in the
supernatant and in cell extracts were immunoprecipitated using
a goat anti-influenza virus antiserum and subjected to SDS-PAGE
and autoradiography.
(C) Quantitation of released NP and M1 in (B).
(D) Expression of viperin inhibits influenza A virus budding. Control or
viperin-inducible cells, untreated or pretreated with doxycycline, were
infected with influenza A/WSN virus for 14 hr and subjected to thin-
section EM.98 Cell Host & Microbe 2, 96–105, August 2007 ª2007 Elseviercontrol cells, measured by immunoprecipitation of deter-
gent-treated supernatants and SDS-PAGE (Figure 2B, up-
per panel; Figure 2C). The intracellular levels of NP andM1
proteins were unaffected (Figure 2B, lower panel).
To characterize more fully the viral release defect, in-
fected cells were examined by thin-section electron mi-
croscopy. In untreated viperin-inducible cells or doxycy-
cline-treated control cells (Figure 2D, upper panels), the
membranes of the progeny virions still attached to the
cell membrane appeared ready for pinching off and re-
lease. In contrast, many of the virions on the surface of
viperin-expressing cells displayed either an abnormal
elongated stalk-like phenotype or a ‘‘daisy-chain’’ struc-
ture inwhich two ormore viral particles appear to be linked
by a connecting membrane (Figure 2D, lower panels). The
images suggest that initial bud formation occurs in viperin-
expressing cells, but the release of progeny virions is in-
hibited. Initiation of assembly of a second virus at a bud-
ding site where a virion is arrested may lead to the
‘‘daisy-chain’’ structure. An analysis of 188 budding
events in viperin-expressing cells showed that 43% of
them displayed either the elongated stalk or ‘‘daisy chain’’
phenotypes, while in non-viperin-expressing infected cells
only 3.6% were abnormal. A similar ‘‘daisy-chain’’ bud-
ding defect has been observed in influenza A viruses
with mutations in the cytoplasmic tail of NA (Barman
et al., 2004), or truncation in the M2 protein (McCown
and Pekosz, 2006). Similar structures have also been
observed in cells infected with HIV late domain mutants
(Garrus et al., 2001).
Expression of Viperin Disrupts Lipid Rafts
Influenza virions bud from lipid raft microdomains on the
plasma membrane (Leser and Lamb, 2005; Scheiffele
et al., 1999). We hypothesized that the budding defect
we observed in viperin-expressing cells may be due to
a disturbance of lipid-raft microdomains on the plasma
membrane. One characteristic of lipid rafts is the poor ex-
traction of raft-associated proteins, such as influenza virus
HA, by nonionic detergents at 4C (Scheiffele et al., 1997).
If viperin expression disrupts lipid raft formation, we would
expect to see an increase in the extraction of HA mole-
cules from viperin-expressing cells in the nonionic deter-
gent Triton X-100. Consistent with this hypothesis, HA
was more readily extracted from viperin-expressing cells
by a low concentration of Triton X-100 at 4C (Figure 3A,
left panel). The detergent solubility of vesicular stomatitis
virus-glycoprotein (VSV-G), which does not associate
with lipid rafts (Scheiffele et al., 1999), was the same in
the presence or absence of viperin, as were the nonmem-
brane proteins influenza NP (Figure 3A, left panel) and VSV
nucleoprotein (N) (Figure 3A, right panel). Lipid raft micro-
domains are highly enriched in sphingolipids, and staining
of the sphingolipid GM1 by the cholera toxin B subunit has
been used to detect them. Lipid raft-associated proteins,
such as the GPI-anchored protein placental alkaline phos-
phatase (PLAP), cluster with cholera toxin-crosslinked
GM1after antibody-induced patching, and the copatching
of lipid-raft associated proteins is significantly reducedInc.
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et al., 1998). We therefore asked whether expression of
viperin could disrupt the coclustering of HA or PLAP in-
duced by specific antibodies andGM1 induced by cholera
Figure 3. Viperin Expression Disrupts Lipid Rafts
(A) Viperin expression enhances extraction of HA by Triton X-100.
Viperin-inducible cells, untreated or treated with doxycycline for
24 hr, were infected with A/WSN virus for 18 hr or with VSV virus for
5 hr at an moi of 5. Cells were then extracted with 0.1% Triton X-100
at 4C for 30 min. After centrifugation, the supernatant (LDS, low-con-
centration detergent-sensitive) was removed, and the pelleted cells
were further extracted with 1% Triton X-100 (HDS, high-concentration
detergent-sensitive). The LDS and HDS extracts were subjected to
SDS-PAGE and western blot analysis using antibodies specific for
HA, NP, VSV-N, and VSV-G proteins. GRP94 was used as a loading
control.
(B) Viperin expression disrupts copatching of HA and GM1. HeLa Tet-
on cells were transiently transfected with HA plus vector or with HA
plus viperin expression plasmids. Forty-eight hours posttransfection,
Alexa 488-conjugated cholera toxin B subunit was used to induce
GM1 patching at room temperature. Patching of HAwas induced using
a monoclonal antibody against HA followed by Alexa 633-conjugated
goat anti-mouse IgG secondary antibody. Cells were fixed and images
acquired using a Leica TCS SP2 confocal microscope. Digital Alexa
633 images were pseudocolored red for better visualization. Copatch-
ing of HA and GM1 was largely disrupted in the viperin-expressing
cells.
(C) Membrane fluidity in viperin-nonexpressing (Dox) and viperin-
expressing (+Dox) cells. HeLa Tet-on RFP-viperin cells were either un-
treated or pretreatedwith doxycycline for 24 hr. Cells were labeled with
DPH, and fluorescent anisotropy was measured.Cell Htoxin. We found that both HA and PLAP copatched with
GM1 in control cells as previously observed (Harder
et al., 1998), but the copatching was largely disrupted by
viperin expression (Figure 3B and Figure S2). This sug-
gests that viperin expression indeed disrupts lipid raft
microdomains.
Previous studies have shown that IFN treatment can
induce an increase in membrane fluidity and in the lateral
diffusion coefficients of certain membrane proteins (Balint
et al., 2005; Nathan et al., 1998). To directly monitor whe-
ther viperin expression leads to a change inmembrane flu-
idity, we measured the membrane anisotropy using 1,6-
diphenyl-1,3,5-hexatriene (DPH) as a probe. We found
a significantly lower anisotropy in doxycycline-induced
viperin-expressing cells compared to untreated viperin-
nonexpressing cells (Figure 3C), reflecting a lower mem-
brane microviscosity and an increase in membrane fluid-
ity. This effect was not due to doxycycline treatment,
because no significant change of membrane anisotropy
was found in the vector alone cells in the presence or
absence of doxycycline (Figure S3). The cumulative data
strongly argue that viperin expression affects lipid raft
formation.
Lipid rafts are tightly packed, liquid-ordered microdo-
mains enriched in sphingolipids and cholesterol. Their
rigid structure results in decreased lateral diffusion of the
membrane proteins in lipid rafts compared to those in liq-
uid-disordered nonraft regions (Shvartsman et al., 2003).
We therefore hypothesized that surface HA molecules in
viperin-expressing cells would exhibit increased mobility
compared to nonexpressing cells. To test this, we used
the technique of fluorescence recovery after photobleach-
ing (FRAP). To facilitate the analysis, we generated an in-
ducible HeLa-derived cell line expressing a red fluores-
cent protein (RFP)-viperin chimera. RFP-viperin was
induced by doxycycline treatment (Figure 4A) and, like
wild-type viperin, it colocalized with calnexin (Figure S4)
and inhibited the replication of influenza A/WSN virus
(Figure 4B). RFP-viperin-inducible cells were either
treated with doxycycline, or left untreated, for 24 hr and
then infected with influenza A virus for 14 hr. Cell surface
HA was labeled with an Alexa 488-conjugated Fab frag-
ment of the HA-specific monoclonal antibody H17-L2
(Arnon et al., 2001) at 4C, and FRAP analysis was con-
ducted at 22C. Typical surface staining and fluorescent
recovery curves of HA expressed on the surface of vi-
perin-expressing and nonexpressing cells are shown in
Figure 4C. Consistent with our hypothesis, viperin expres-
sion increased the lateral diffusion rate of HA. The half-life
of fluorescence recovery (T1/2) was significantly reduced
in viperin-expressing cells compared to control cells (T1/2
of 33.2 s versus T1/2 of 59.0 s; Figure 4D, upper panel). Vi-
perin expression increased the lateral diffusion coefficient
of HA by a factor of 2, which is consistent with a change of
an ordered lipid phase to a disordered lipid phase (Al-
meida et al., 1993). The rate of fluorescence recovery for
VSV-G, a transmembrane glycoprotein that is not raft
associated, was unchanged by viperin expression (T1/2
of 26.5 s versus T1/2 of 26.4 s; Figure 4D, lower panel).ost & Microbe 2, 96–105, August 2007 ª2007 Elsevier Inc. 99
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Lateral Mobility of Influenza HA
(A) Expression of RFP-viperin in HeLa Tet-
on viperin-inducible cells. The RFP-viperin-
inducible cells were untreated () or treated
(+) with 2 mg/ml doxycycline for 16 hr. Cell ly-
sates were subjected to Western blot analysis
using an antiserum recognizing both human
and mouse viperin. Cell lysates of doxycy-
cline-treated HeLa Tet-on cells expressing un-
tagged viperin were used as a control (Ctl).
GAPDH was used as a loading control.
(B) RFP-viperin antiviral activity for influenza
A/WSN virus. RFP-viperin-inducible cells
were untreated or treated with doxycycline, in-
fected, and supernatants were subjected to
a plaque assay as in Figure 2A.
(C) Staining of surface HA bymonovalent Alexa
488-conjugated H17-L2 Fab, the expression of
RFP-viperin, and a representative FRAP curve
in RFP-viperin-expressing (+Dox) or nonex-
pressing (Dox) cells.
(D) Fluorescence recovery half-lives of influ-
enza HA and VSV-G-GFP molecules. For HA,
cells were either untreated (Dox) or treated
with doxycycline (+Dox) for 24 hr and infected
with influenza A/WSN virus for 14 hr at an
moi of 3. Cells were stained with Alexa 488-
conjugated H17-L2 Fab on ice for 30 min. A
minimum of 12 cells in each category were
subjected to FRAP analysis. Statistical signifi-
cance (***p < 0.001 for Dox versus +Dox
cells) by Student’s t test. For VSV-G, RFP-
viperin-inducible cells were transfected with
VSV-G-GFP expression plasmid for 24 hr. Cells
were then either untreated (Dox) or treated
with doxycycline (+Dox) for another 24 hr.
Thirty-threeDox and 29 +Dox cells were sub-
jected to FRAP analysis. Statistical signifi-
cance (p = 0.97 for Dox versus +Dox cells)
was determined by Student’s t test.
(E) Expression of viperin does not inhibit VSV
replication. HeLa Tet-on viperin-inducible cells
were untreated or treated with doxycycline for
16 hr and infected with VSV at an moi of 0.001.
Viral titers were determined at 0, 8, 30, 48, and
72 hr postinfection by plaque assay.Significantly, the replication of VSV, which does not in-
volve lipid rafts, was not affected by the expression of vi-
perin (Figure 4E). These observations further support the
hypothesis that viperin expression inhibits the release of
influenza virus by disrupting lipid rafts.
Viperin Interacts with and Inhibits Farnesyl
Diphosphate Synthase
To investigate further the antiviral mechanism, we looked
for viperin-interacting proteins using yeast two-hybrid
screening. A cDNA corresponding to farnesyl diphosphate
synthase (FPPS) was isolated. FPPS is a key enzyme in the
isoprenoid biosynthetic pathway: it catalyzes the sequen-
tial condensation of dimethyallyl pyrophosphate with two
molecules of isopentenyl diphospate to form farnesyl py-
rophosphate (FPP). FPP is a biosynthetic precursor of100 Cell Host & Microbe 2, 96–105, August 2007 ª2007 Elseviecholesterol, farnesylated and geranylated proteins, ubi-
quinones, dolichols and heme a (Szkopinska and Plo-
chocka, 2005). We confirmed that endogenous FPPS
and viperin interacted in vivo in IFN-treated mouse
RAW264.1 cells by coimmunoprecipitation (Figure 5A).
We also found that viperin expression in HeLa Tet-on cells
led to a reduction in FPPS enzymatic activity, by 20% after
24 hr and 50% after 48 hr of doxycycline treatment
(Figure 5B).
Overexpression of FPPS Reverses
the Viperin Effects
Because FPPS is a pivotal enzyme involved in lipidmetab-
olism, and viperin inhibited its activity, we tested whether
overexpression of FPPS could reverse the increased lat-
eral mobility of plasma membrane HA molecules inducedr Inc.
Cell Host & Microbe
Viperin Inhibits Influenza Virus Releaseby viperin. HeLa Tet-on cells were transfected with vector
alone, RFP-viperin expression plasmid plus the vector, or
a mixture of the RFP-viperin and FPPS expression plas-
mids. At 24 hr posttransfection, the cells were infected
with influenza A/WSN virus at an moi of 3. Cell surface
HA was labeled with fluorescent anti-HA Fab 14 hr postin-
fection, and FRAP analysis was conducted. As we ob-
served in the RFP-viperin-inducible cells, transiently ex-
pressed RFP-viperin significantly increased the lateral
mobility of HA compared to control cells (recovery T1/2
of 27.2 s versus 48.2 s; Figure 6A). Importantly, coexpres-
sion of FPPS reversed the viperin effect, increasing the T1/
2 for recovery to 51.2 s (Figure 6A). In addition, we found
that in vitro loading of exogenous cholesterol, one of the
downstream products of FPPS, into viperin-expressing
cells significantly decreased the lateral mobility of HA (re-
covery T1/2 of 35.7 s versus T1/2 of 23.8 s, Figure 6B).
These data suggest that the enhanced membrane fluidity
upon viperin expression is caused by its inhibition of FPPS
Figure 5. Viperin Interacts with FPPS and Inhibits Its Activity
(A) Endogenous viperin interacts with FPPS. RAW264.1 cells were ei-
ther untreated () or treated (+) with IFN-b for 16 hr. Expression of vi-
perin and FPPS were determined by western blotting (upper panels).
Phosphoglycerate mutase 1 (PGAM1) was used as a loading control.
Cell lysates were also immunoprecipitated with mouse anti-viperin
mAb. A mouse mAb to mouse GILT, a protein highly expressed in
RAW264.1 cells, was used as a control. Immune complexes were sep-
arated by SDS-PAGE, and FPPS was detected by western blotting
(lower panel).
(B) The activity of FPPS is reduced by viperin expression. Control and
viperin-inducible cells were either untreated or treated with doxycy-
cline for 24 hr and 48 hr. FPPS activity was determined by synthesis
of 14C-FPP from geranyl pyrophosphate and 14C-isopentenyl pyro-
phosphate. The values in doxycycline-treated cells were normalized
to their untreated counterparts.Cell Hactivity, and that cholesterol metabolismmight be a factor
contributing to the effect. Since FPPS catalyzes the bio-
synthesis of FPP, a precursor for protein isoprenylation,
we also testedwhether the inhibition of FPPS by viperin af-
fected isoprenylation of the cellular proteins Cdc42
(Figure S5), Rab5, and RhoB (data not shown). Treatment
of the cells with lovastatin, an inhibitor of HMG reductase,
which acts upstream of FPPS in the biosynthetic pathway,
Figure 6. Overexpression of FPPS Reverses the Antiviral
Activity of Viperin
(A) Expression of FPPS in viperin-expressing cells restores the normal
lateral diffusion rate of HA. HeLa Tet-on cells were transiently trans-
fected with combinations of vectors encoding RFP-viperin or FPPS
for 24 hr, infected with influenza A/WSN virus, subjected to FRAP anal-
ysis as described in Figure 4D, and the half-lives of recovery were cal-
culated. For nontransfected cells versus RFP-viperin-transfected
cells, **p < 0.01; for nontransfected cells versus RFP-viperin- and
FPPS-cotransfected cells, p > 0.05; for RFP-viperin-transfected ver-
sus RFP-viperin- and FPPS-cotransfected cells, **p < 0.01.
(B) In vitro loading of cholesterol partially restores the normal fluores-
cence recovery half-lives of influenza HA. For HA, cells were either un-
treated (Dox), treated with doxycycline (+Dox), or treated with a com-
bination of doxycycline and cholesterol (+Dox +Cholesterol) for 24 hr
and infected with influenza A/WSN virus for 14 hr at an moi of 3.
FRAP analysis was conducted as in (A), and a minimum of 27 cells in
each category were subjected to FRAP analysis. Statistical signifi-
cance (***p < 0.001 for Dox versus +Dox; *p < 0.05 for +Dox versus
+Dox+Cholesterol, and p > 0.05 for Dox versus +Dox+Cholesterol)
was determined by the one-way ANOVA method.
(C) FPPS expression restores viral release in viperin-expressing cells.
HeLa Tet-on cells were transiently transfected with vector, viperin,
FPPS, or viperin plus FPPS expression plasmids. After 24 hr, cells
were infected with influenza A/WSN virus for 16 hr, pulse-labeled
with 35S-methionine and cysteine for 20 min, and chased for 2 hr. Su-
pernatants and cell lysates were immunoprecipitated and subjected to
SDS-PAGE and autoradiography as in Figure 2B.
(D) FPPS abrogates the viperin-mediated inhibition of influenza A/WSN
virus replication. HeLa Tet-on cells transiently transfected as in (C)
were infected with influenza A/WSN virus at an moi of 0.02. Virus titers
in the supernatant were determined by plaque assay 24 hr postinfec-
tion. One of two representative experiments is shown.ost & Microbe 2, 96–105, August 2007 ª2007 Elsevier Inc. 101
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therefore reduced partitioning into Triton X-114 detergent
fractions. However, no such inhibition was detected in vi-
perin-expressing cells (Figure S5). This argues that the an-
tiviral activity of viperin is not likely to be mediated by
a general reduction in protein isoprenylation.
We next examined whether overexpression of FPPS in
viperin-expressing cells could restore influenza virus pro-
duction. HeLa Tet-on cells transiently transfected with
plasmids encoding viperin or FPPScDNA, orwith a combi-
nation of the two, were infected with influenza A/WSN vi-
rus. The cells were pulse labeled with 35S-methionine and
chased, and virus release into the supernatant was
assessed. Consistent with the results obtained with the
inducible cells (Figure 2B), transiently expressed viperin
inhibited viral release (Figure 6C). Importantly, coexpression
of FPPS largely reversed the inhibition (Figure 6C). Viral
titers in the transiently transfected cells were also deter-
mined at 24 hr postinfection, and coexpression of FPPS
consistently reversed the observed viperin-induced de-
crease in virus production (Figure 6D).
Reduction of FPPS Expression by siRNA Inhibits
Influenza Replication and Release
To further study the functional significance of FPPS in the
viral replication cycle, we used specific siRNA oligonucle-
otides to efficiently reduce cellular FPPS levels (Figure 7A).
Inhibition of FPPS expression led to a decrease in the viral
titer produced by infected cells of approximately 10-fold
(Figure 7B). Consistent with the effects seen in viperin-
expressing cells (Figure 2B), knocking down FPPS also
inhibited viral release measured directly by metabolic la-
beling and immunoprecipitation. Quantitation of the
SDS-PAGE bands indicated that the amounts of viral pro-
tein released by the infected cells were reduced by ap-
proximately 50% (Figure 7C). These observations suggest
that the viperin-induced inhibition of influenza virus re-
lease is at least partially mediated by its ability to bind
and inhibit FPPS.
DISCUSSION
Among the hundreds of interferon-inducible proteins,
there are only a few for which an antiviral mechanism
has been defined. Induction of PKR and 2050-OAS leads
to an inhibition of protein synthesis and therefore prevents
viral replication (Clemens and Elia, 1997; Kerr and Brown,
1978). ISG15 blocks ubiquitination of viral and cellular pro-
teins important for HIV release (Okumura et al., 2006). Our
data demonstrate that viperin inhibits the release of influ-
enza virus at the final step in the viral life cycle, the release
of the budding virus from the plasma membrane. This is
a consequence of viperin-induced disruption of lipid-raft
microdomains, and the data suggest that this results
from an interaction of viperin with the enzyme FPPS that
inhibits FPPS activity. Inhibition of the release stage of
the viral replication cycle by disrupting lipid rafts has not
previously been identified as a target of an interferon-
inducible protein.102 Cell Host & Microbe 2, 96–105, August 2007 ª2007 ElseviLipid rafts play an important role in the replication cycle
of many viruses. The envelopes of both influenza virus and
HIV are enriched in raft lipids (Scheiffele et al., 1999; Brug-
ger et al., 2006), and the budding process is initiated by
the accumulation of viral envelope proteins in lipid rafts.
Viperin expression reduced the extraction of lipid raft-
associated HA by Triton X-100, commonly used to evalu-
ate the association of membrane proteins with rafts, and
also reduced copatching of the raft-associated sphingoli-
pid GM1 with PLAP, a raft-associated protein, and, more
importantly, with HA itself. FRAP analysis further showed
that the lateral mobility of HA in the plasma membrane
of viperin-expressing cells was increased, while the lateral
mobility of the non-raft-associated transmembrane glyco-
proteins VSV-G was unaffected. In agreement with the hy-
pothesis that these changes are directly responsible for
the inhibitory effect of viperin, replication of VSV, which
Figure 7. FPPS Plays an Important Role in Influenza A Viral
Replication and Release
(A) Specific knockdown of FPPS by siRNA. HeLa cells were trans-
fected twice with either control or FPPS-specific siRNA oligonucleo-
tides at 24 hr intervals. Cell lysates were made 24 hr after the second
transfection, subjected to SDS-PAGE, and immunoblotted with rabbit
anti-FPPS antibody or rabbit anti-ERp57 antibody as a control.
(B) RNAi knockdown of FPPS inhibits influenza A/WSN replication.
HeLa Tet-on cells were transfected with control or FPPS siRNA oligo-
nucleotides as described in (A) and infected with influenza A/WSN vi-
rus at 24 hr after the second transfection. Viral titers in the supernatant
were determined by plaque assay.
(C) RNAi knockdown of FPPS inhibits influenza A virus release. HeLa
Tet-on cells were transfected as in (B). Ten hours after the second
siRNA transfection, cells were infected with influenza A/WSN virus at
anmoi of 3. After 14 hr, the cells were pulse labeled, virus was released
into the supernatant, and cellular viral proteins were immunoprecipi-
tated at 3, 4, and 6 hr postchase and subjected to SDS-PAGE as de-
scribed in Figure 2B.er Inc.
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sion. Viperin expression was recently shown to partially in-
hibit single-cycle VSV-pseudotyped HIV viral replication
(Rivieccio et al., 2006), and it will be interesting to deter-
mine whether perturbation of lipid rafts by viperin also
plays a role in controlling HIV infection.
The enzyme FPPS is a key player in the antiviral mech-
anism. Viperin binds to FPPS intracellularly and inhibits
the activity of the enzyme. Although viperin is localized
at the ER, we have shown that it resides at the cytoplasmic
face, which is consistent with such an interaction (unpub-
lished data). Inhibiting FPPS expression by siRNA affected
influenza virus replication in a similar manner to viperin,
namely by blocking viral release. Moreover, overexpres-
sion of FPPS in viperin-expressing cells reversed the in-
creased fluidity of the plasma membrane and rescued in-
fluenza viral replication and release.We have attempted to
determine which of the pathways downstream of FPPS is
the key for the viperin-mediated effect. To date, the com-
plexity of the FPPS pathway has rendered this ultimate
goal elusive, but one can envision a number of possible
mechanisms. Many cellular GTPases, such as members
of the Ras family, are involved in intracellular vesicular
transport, and many if not all are isoprenylated (Hancock
et al., 1989). Isoprenoids such as farnesyl and geranylger-
anyl lipids require FPPS for their synthesis, but we were
unable to demonstrate an effect of viperin expression on
the isoprenylation of candidate proteins. The fact that in
vitro addition of cholesterol could partially restore normal
fluidity in viperin-expressing cells suggested that choles-
terol depletion could play a role. However, we have been
unable to detect significant differences in the absolute
levels of cholesterol or the rates of cholesterol biosynthe-
sis between viperin-expressing and nonexpressing cells
(data not shown). Nevertheless, the data clearly support
a role for FPPS inhibition in the mechanism of action of vi-
perin, and the observation that reducing FPPS levels by
siRNA oligonucleotides affects influenza virus replication
by perturbing membrane fluidity suggests a new thera-
peutic approach to controlling influenza virus infection.
EXPERIMENTAL PROCEDURES
Viruses, Cells, and Antibodies
Influenza A/WSNandA/PR8 viruseswere kindly provided byDr. Adolfo
Garcia-Sastre. HeLa Tet-on cells were from Clontech. RAW261.4 cells
were from ATCC. Goat anti-influenza antiserum was purchased from
Chemicon. Rabbit antiserum to FPPSwas kindly provided by Dr. Peter
Edwards. The anti-HA mAb H17-L2 was kindly provided by Dr. Jona-
than Yewdell. Goat anti-PGAM1 antiserum was from Abcam. Mono-
clonal Abs to GAPDH and GRP 94 were from Research Diagnostics.
The anti-viperin mAb MaP.VIP was generated against the C-terminal
domain of mouse viperin (amino acids 92–362).
Plasmids and Transfections
Mouse viperin was amplified from LPS-treated mouse primary macro-
phage cDNA and cloned into pCDNA3.1 vector between EcoRI and
BamHI sites using the following primers: 50-GGCCGAATTCAGGTG
TGTGCCTATCACCATG-30 and 50-GCGCGGATCCATCTCAGCCTCA
CCAGTCCA-30. FPPS was amplified from NIH 3T3 cells cDNA and
cloned between the same restriction sites using primers 50-GCGCGAACell HosTTCGCCATGAATGGGAACCAGAAA-30 and 50-GCGCGGATCCCTTT
CTCCGTTTGTAGATCTT-30. For some experiments, plasmids were
transfected into HeLa Tet-on cells using Lipofectamine 2000 (Invitro-
gen) according to the manufacturer’s recommendations. Transfection
efficiencies were routinely determined by immunofluorescence and
were minimally 85%.
HeLa Tet-on Viperin-Inducible Cells
Mouse viperin cDNA was subcloned into the pTRE-tight vector (Clon-
tech). HeLa Tet-on cells were cotransfected with pTRE-tight viperin
and a hygromycin resistance gene (Clontech). Positive clones were se-
lected in the presence of G418 and hygromycin, and the inducibility of
viperin was then determined by western blot analysis using a rabbit an-
tiserum to viperin.
Immunofluorescence
Doxycycline-treated HeLa Tet-on viperin-inducible cells were fixed
with 3.75% formaldehyde, permeabilized with 0.05% saponin, and
stained with MaP.VIP and rabbit antibody to calnexin, followed by
Alexa Fluor 546-conjugated goat anti-rabbit and Alexa Fluor 488-
conjugated goat anti-mouse antisera (Molecular Probes). Images
were acquired with a Leica TCS SP2 confocal microscope.
Radiolabeling and Immunoprecipitation
To examine the release of influenza A/WSN virus in the supernatant
and viral proteins remaining in the cytosol, untreated or doxycycline-
treated HeLa Tet-on viperin-inducible cells, or transfected HeLa Tet-
on cells, were first infected with influenza A/WSN virus, deprived of
methionine and cysteine for 30min, pulse-labeled with 35S-methionine
and cysteine for 20 min, and chased for the noted intervals. Triton
X-100 was added to the supernatants to a final concentration of
0.5%. Cells were lysed in Tris-buffered saline (pH 7.4) containing
1% Triton X-100. Immunoprecipitations were performed using 5 ml
goat anti-influenza antiserum (Chemicon) and protein G Sepharose
(Amersham), followed by SDS-PAGE.
Electron Microscopy
Thin-section electron microscopy was performed as previously de-
scribed (Barman et al., 2003). Briefly, HeLa Tet-on vector or viperin-
inducible cells were either untreated or treated with doxycycline for
24 hr and infected with A/WSN virus for 14 hr. Cells were fixed with
2.5% glutaraldehyde and postfixed with 1% osmiun tetroxide. Cells
were en bloc stained with 2% uranyl acetate, dehydrated, infiltrated,
and embedded in Epon. Sixty nanometer sections were stained
with lead citrate and examined using a Tecnai 12 Biotwin electron
microscope.
Antibody- and Cholera Toxin-Induced Patching
The copatching experiment was performed as described (Harder et al.,
1998). Mouse anti-PLAPmonoclonal antibody (NOVUSBiological) and
mouse anti-HA monoclonal antibody H17-L2 were diluted 1:100, and
Alexa 488-conjugated cholera toxin B subunit (Invitrogen, Molecular
Probes) was used at 8 mg/ml. Cells were first washed in ice-cold
PBS and then incubated with either PLAP or HA antibody and fluores-
cent cholera toxin B subunit at room temperature for 30min. Cells were
thenwashed briefly with ice-cold PBS and further incubatedwith Alexa
633 conjugated goat anti-mouse antibody for 30 min at room temper-
ature. After washing with cold PBS, cells were fixed for 4 min in 3.7%
formaldehyde at 4C and subsequently incubated with methonal at
20C for 5 min. Mounted cells were visualized, and images were
acquired with a Leica TCS SP2 confocal microscope. For better visu-
alization, Alexa 633 images were pseudocolored red using the Image
J program.
Membrane Fluorescence Anisotropy Measurements
Membrane fluidity was determined by measuring fluorescence anisot-
ropy in viperin-expressing cells and nonexpressing cells, using 1,6-
diphenyl-1,3,5-hexatriene (DPH) (Sigma) as a probe. Cells weret & Microbe 2, 96–105, August 2007 ª2007 Elsevier Inc. 103
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with DPH (4 mM). After washing the samples, fluorescence was mea-
sured at excitation wavelength 375 nm and emission wavelength
425 nm using a spectrofluorimeter (Photon Technology International).
The anisotropy value was calculated as r = (IVV  G.IVH)/(IVV + 2G.IVH)
with G = IHV/IHH, IHH = I(L)HH I(buffer + cell)HH I(buffer + probe)HH + I(buffer)HH
[I(L), fluorescence intensity of DPH probe-labeled cell suspension;
I(buffer + cell), fluorescence intensity of nonlabeled cell suspension;
I(buffer + probe), fluorescence intensity of buffer incubated with the DPH
probe; I(buffer), fluorescence intensity of buffer alone].
FRAP Analysis
HeLa Tet-on RFP-inducible cells, either untreated or treated with
doxycycline for 24 hr, were infected with influenza A/WSN virus
for 14 hr. Cells were stained with Alexa 488-conjugated H17-L2 Fab
on ice. FRAP analyses were conducted using a Leica TCS SP2 confo-
cal microscope. Ten frames were collected at 0.834 s/frame before
a 5 3 2 mm2 area was photobleached at 40% laser power for 0.834 s.
Fluorescence recovery was monitored by capturing confocal images
at 3% laser power for 100 frames.
Yeast Two-Hybrid Screening
The Matchmaker GAL4 yeast two-hybrid system and a mouse embry-
onic fibroblast cDNA library (Clontech) were used. Mouse viperin
cDNA was cloned into the pGBKT7 vector, and experiments were car-
ried out following the manufacturer’s instructions.
FPPS Activity Assay
FPPS activity was assayed as described (Reilly et al., 2002). Untreated
and doxycycline-treated viperin-inducible cells were scraped into
FPPS assay buffer. Lysates were cleared by centrifugation at 16,000 g
for 10 min. Reactions were carried out in assay buffer containing
18 mM geranyl pyrophosphate, 13.3 mM [1-14C] isopentenyl pyrophos-
phate, and 10 mg cell lysate protein at 37C for 45 min. Samples were
acidified, incubated in the presence of unlabeled farnesol at 37C for
30 min to hydrolyze the FPP to farnesol, and then neutralized with
10% NaOH. Farnesol was extracted into hexane, and the organic
phase was removed for liquid-scintillation counting.
Triton X-114 Partitioning
HeLa Tet-on vector cells or HeLa Tet-on viperin-inducible cells were
either untreated or treated with doxycycline or lovastatin (5 mM) for
24 hr. Similarly to previously described methods (Overmeyer and Mal-
tese, 1992), cells were lysed in 1% Triton X-114 in TBS with protein in-
hibitor cocktail on ice. Insoluble material was pelleted at 13,000 rpm for
10 min. Soluble factions were incubated at 37C to promote phase
separation, and the detergent phase was separated from the aqueous
phase by centrifuging at 13,000 rpm for 1min. The aqueous phase was
removed and brought to 1% Triton X-114 by adding a 10% solution,
and the concentration in the detergent phase was reduced to 1% by
adding TBS. Protein concentration was then determined by the
Bradford method, and equal amounts of protein were subjected to
western blot analysis using antibodies specific for Cdc42, Rab5, and
RhoB.
siRNA Transfection
Control and FPPS-specific siRNAs were obtained from Dharmacon.
Briefly, 13 105 HeLa Tet-on cells were plated in 12-well tissue culture
plates. Fivemicroliters of 20 mMsiRNA oligos was diluted to 100 ml, and
2 ml oligofectamine (Invitrogen) was used for each transfection follow-
ing the manufacturer’s recommendations. Twenty-four hours post-
transfection, the cells were replated in one well of a 6-well plate to ob-
tain 50% confluence the next day. Cells were transfected again with
10 ml of 20 mMsiRNA oligos. Knockdown efficiency of FPPSwas deter-
mined by western blot analysis.104 Cell Host & Microbe 2, 96–105, August 2007 ª2007 ElseviSupplemental Data
The Supplemental Data include five supplemental figures and one sup-
plemental movie and can be found with this article online at http://
www.cellhostandmicrobe.com/cgi/content/full/2/2/96/DC1/.
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